Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.45 CHF | +0.84% | -.--% | -.--% |
05-02 | QIAGEN Announces the Availability of QCI Secondary Analysis | CI |
04-30 | QIAGEN NV : Berenberg reaffirms its Buy rating | ZD |
Sales 2024 * | 2.01B 1.82B 2.74B | Sales 2025 * | 2.14B 1.94B 2.92B | Capitalization | 9.45B 8.57B 12.91B |
---|---|---|---|---|---|
Net income 2024 * | 404M 367M 552M | Net income 2025 * | 450M 408M 615M | EV / Sales 2024 * | 4.87 x |
Net Debt 2024 * | 325M 295M 444M | Net cash position 2025 * | 206M 187M 282M | EV / Sales 2025 * | 4.32 x |
P/E ratio 2024 * |
23.4
x | P/E ratio 2025 * |
21
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.67% |
Latest transcript on Qiagen N.V.
Managers | Title | Age | Since |
---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 15-01-31 |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Roland Sackers
DFI | Director of Finance/CFO | 56 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 11-05-31 | |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Lawrence Rosen
CHM | Chairman | 66 | 13-06-25 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- QGEN Stock
- QGEN Stock